skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All









99+ Total results for product and free and sample content found


Top 10 Best-Selling Drugs of 2020

One hundred billion dollars. That is the combined revenue of the top 10 pharmaceuticals in 2020, marking the first year in which this threshold has been crossed.

Topic drug-review drug-pricing

Generics Bulletin: ジェネリック&バイオシミラーニュース

Glenmark Debuts Favipiravir For COVID-19 In India

Glenmark has received the go-ahead in India for and launched its low-priced favipiravir product for mild to moderate COVID-19 under an accelerated approval process.

Topic Coronavirus drug-review

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

What Did US FDA Do Wrong In Its Review Of Aducanumab AdCom Members Have A List

Committee members rebuked FDA for its positive review of Biogen’s Alzheimer’s disease drug, objecting to its ‘terrifically one-sided’ analysis of data, the short shrift given the contrary conclusions of its own statistician, and its interpretation of a dosing study to support the sole positive Phase III study.

Topic advisory committees drug-review fda

Scrip: 世界の医療用医薬品&製薬産業に関するニュース, Datamonitor He...

Top 10 Best-Selling Drugs of 2019

In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.

Topic Drug Review Diseases

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Massive Reallocation of UK Rapporteurships Likely As EMA Plans For Future; UK’s Interim Role Uncertain

If Brexit means the UK no longer plays a part in the EU drug regulatory system, responsibility for the ongoing oversight of almost one in four of all the human medicines that have ever been approved under the centralized procedure will have to be reassigned from the UK to other member states. What Brexit means for the UK’s role as a key player in the regulatory system in the meantime is the subject of speculation.

Topic Brexit Drug Review Life Cycle Management

Pharmaprojects: 医薬品開発パイプラインのデータベース



世界の医薬品産業における研究開発トレンドを検証する年次ホワイトペーパー『Pharma R&D Annual Review 2020』が発行されました。1980年以来、弊社が追跡してきた世界の医薬品情報の蓄積を駆使して、会社別、治療領域別、疾病別、標的および剤型別にパイプラインを検証し、業界トレンドを評価しました。

Topic drug-development-landscape drug-review research

Pharmaprojects: 医薬品開発パイプラインのデータベース, Biomedtra...

The Race to Find a COVID-19 Treatment - Infographic

The Race to Find a COVID-19 Treatment - Infographic

Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.

Topic Coronavirus FDA Drug Review




新たな10年の幕開けとともに、医薬品産業のR&Dはどこへ向かおうとしているのでしょうか。世界の製薬業界における研究開発トレンドを検証する無料ホワイトペーパー『Pharma R&D Annual Review 2020(全40頁)』が発行されました。それに合わせて、ポイントを視覚的に分かりやすく表現したインフォグラフィックも作成しました。

Topic drug-development-landscape drug-review research